Rescue Stenting for Failed Endovascular Thrombectomy in Acute Ischemic Stroke (ReSET)
NCT ID: NCT03993340
Last Updated: 2021-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
78 participants
OBSERVATIONAL
2019-06-24
2021-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Rescue Stenting/Angioplasty After Failed Thrombectomy for Acute Large Intracranial Vascular Occlusion
NCT07026344
Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke
NCT03370939
First-pass Recanalization With EmboTrap II in Acute Ischemic Stroke (FREE-AIS)
NCT04310306
Intracranial Rescue Stenting for Acute Ischemic Stroke, Predictors of Outcomes
NCT04987710
Rescue Intracranial Stenting in Acute Ischemic Stroke
NCT04986774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Rescue stenting group
Rescue stenting
The subjects will receive endovascular treatment for acute stroke according to standard clinical practice. Specifically, modern endovascular thrombectomy using a stent retriever, contact aspiration thrombectomy, or both are allowed. The number of thrombectomy attempts is at the operator's discretion. After failure of standard thrombectomy procedure, rescue stenting with Solitaire will be done. Additional balloon angioplasty, glycoprotein IIb/IIIa inhibitor (GPI), or thrombolytic infusions are optional and at the operator's discretion. After successful recanalization with rescue stenting, intravenous maintenance of GPI at least for a 12 hours and then changed to oral antiplatelet are recommended.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rescue stenting
The subjects will receive endovascular treatment for acute stroke according to standard clinical practice. Specifically, modern endovascular thrombectomy using a stent retriever, contact aspiration thrombectomy, or both are allowed. The number of thrombectomy attempts is at the operator's discretion. After failure of standard thrombectomy procedure, rescue stenting with Solitaire will be done. Additional balloon angioplasty, glycoprotein IIb/IIIa inhibitor (GPI), or thrombolytic infusions are optional and at the operator's discretion. After successful recanalization with rescue stenting, intravenous maintenance of GPI at least for a 12 hours and then changed to oral antiplatelet are recommended.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Age 19 or greater
* 3\. mRS before qualifying stroke, 0 or 1
* 4\. Baseline NIHSS score 4 or more
* 5\. CT ASPECTS \> 6 or MR ASPECTS \> 5
* 6\. Good collateral statues on CT angiogram (collateral grade by Calgary group, 4 or 5) or corresponding to DEFUSE 3 or DAWN trial on perfusion imaging.
* 7\. Onset (last-seen-well) time to femoral puncture time \< 24 hours
* 8\. Failure of mechanical thrombectomy with stent retriever, contact aspiration or both
* 9\. Subjects who received rescue stenting after failure of mechanical thrombectomy
* 10\. Anticipated life expectancy of at least 12 months
* 11\. Signed informed consent for study enrollment
Exclusion Criteria
* 2\. Multiple simultaneous large vessel occlusions
* 3\. Pregnancy
* 4\. Severe contrast allergy or absolute contraindication to iodinated contrast agent
* 5\. Patient has a severe or fatal combined illness that will prevent improvement of follow-up or will render the procedure unlikely to benefit the patient.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Severance Hospital Stroke Center, Yonsei University College of Medicine
Seoul, Yeonsei-ro Seodaemun-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2018-1148
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.